Erythrocyte Transfusion Based on the Measurement of Central Venous Oxygen Saturation in Postopera… (NCT02963883) | Clinical Trial Compass
CompletedNot Applicable
Erythrocyte Transfusion Based on the Measurement of Central Venous Oxygen Saturation in Postoperative Cardiac Surgery
France160 participantsStarted 2016-12
Plain-language summary
Postoperative erythrocytes transfusion is associated with morbidity and excess mortality, which should lead to ask the indication for RBC transfusions only on metabolic needs. Currently, the majority of studies used to put hemoglobin values indicating red cell transfusions. Two observational studies have confirmed that a transfusion strategy based on a metabolic index (ScvO2) individual was accompanied by a different transfusion strategy than using the hemoglobin threshold values. We propose to conduct the first randomized multicenter study to evaluate erythrocyte transfusion strategy in postoperative cardiac surgery using the ScvO2 each patient versus a threshold value usually recommended for all patients.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Patient ≥ 18 years
✓. programmed cardiac surgery
✓. Central venous catheter placed in territory SVC
✓. Affiliation to a social security system
✓. Hemoglobin \<9 g / dL (transfusion threshold retained by the recommendations the HAS in November 2014 for perioperative patients with cardiovascular antecedents)
Exclusion criteria
✕. Patient minor or under court protection
✕. Pregnant or lactating women
✕. severe acute hemorrhagic syndrome (defined by bleeding rate greater than 1.5 ml / kg / hour for 6 consecutive hours and / or surgical revision within the first 24 postoperative hours)
✕. Installation of an external or internal circulatory support
✕. emergency surgery (\<24 hours from admission)